Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis

February 1996

Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

Rilutek inhibits the release of glutamate...and seems to improve survival by about 3 months.

If you need info about getting Rilutek, call 800/790-7832.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote